Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     

  • Bitcoin GBP

    51,144.41
    -750.30 (-1.45%)
     

  • CMC Crypto 200

    1,331.31
    -65.23 (-4.67%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.68
    +0.11 (+0.13%)
     

  • GOLD FUTURES

    2,348.40
    +5.90 (+0.25%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

European shares edge up, led by Metro, LafargeHolcim

Reuters - UK Focus

LONDON, Nov 25 (Reuters) - European shares edged up on Wednesday, buoyed after German retailer Metro (Other OTC: MTRAF - news) and construction firm LafargeHolcim (Other OTC: HCMLY - news) both announced new dividends.

The pan-European FTSEurofirst 300 edged 0.1 percent higher to 1,482.38 by 0810 GMT, having fallen 1.6 percent over the first two sessions of the week.

German retailer Metro gained 5 percent after it raised its annual dividend more than expected and said it would pay out more of its profits every year from now on, citing the positive effects of restructuring and significantly improved net debt.

LafargeHolcim was also buoyed by a dividend announcement after it proposed a dividend that was higher than the one it suggested earlier this year, despite seeing profit miss expectations.

ADVERTISEMENT

On the downside, Shire (Xetra: S7E.DE - news) fell 1.5 percent after a source told Reuters that the UK-listed pharmaceutical firm is preparing to make a new takeover offer for U.S (Other OTC: UBGXF - news) . biotech firm Baxalta (Berlin: 9BX.BE - news) .

(Reporting by Alistair Smout, Editing by Kit Rees)